| Product NDC: | 60432-264 |
| Proprietary Name: | Fluticasone |
| Non Proprietary Name: | Fluticasone Propionate |
| Active Ingredient(s): | 50 ug/1 & nbsp; Fluticasone Propionate |
| Administration Route(s): | NASAL |
| Dosage Form(s): | SPRAY, METERED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60432-264 |
| Labeler Name: | Morton Grove Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078492 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120109 |
| Package NDC: | 60432-264-15 |
| Package Description: | 1 BOTTLE, SPRAY in 1 BOX (60432-264-15) > 120 SPRAY, METERED in 1 BOTTLE, SPRAY |
| NDC Code | 60432-264-15 |
| Proprietary Name | Fluticasone |
| Package Description | 1 BOTTLE, SPRAY in 1 BOX (60432-264-15) > 120 SPRAY, METERED in 1 BOTTLE, SPRAY |
| Product NDC | 60432-264 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fluticasone Propionate |
| Dosage Form Name | SPRAY, METERED |
| Route Name | NASAL |
| Start Marketing Date | 20120109 |
| Marketing Category Name | ANDA |
| Labeler Name | Morton Grove Pharmaceuticals, Inc. |
| Substance Name | FLUTICASONE PROPIONATE |
| Strength Number | 50 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |